Abstract

This article is an analysis of scientific publications that reflect the experience of using autologous plateletrich plasma in patients with androgenic alopecia (AGA), a multifactorial genetically predisposed disease caused by the influence of exogenous or endogenous triggers responsible for the clinical manifestations of pathology. Attention to this topic is due to the significant prevalence of AGA, as well as unsatisfactory results in achieving a positive therapeutic effect. Positive results were obtained during the 12 clinical studies among the conducted ones, no positive dynamics were observed in the end of other 2 studies. It can be noted that different methods and parameters of centrifugation were used to perform these experiments: PRP used differ or PRP activators were not used at all, variations were observed in methods for evaluating the obtained results, the multiplicity of procedures and intervals between them, the procedure technique (using a mezoroller, anesthetics, injections, etc.). Studies with a negative result were characterized by the smallest number of procedures performed (1 or 2 procedures), and methods for evaluating the results cannot be called sufficiently reliable (a magnifying glass). It is obvious that the use of PRP has a positive effect on the state of AGA and can be used with approved methods of this disease treatment. However, the published results of only a small number of clinical trials on the effectiveness of PRP for hair growth cannot be considered objective. In addition, there is no published agreed protocol for the standard use of PRP, and the use of growth factors and stimulants in the expression of their genes still requires comparative evaluation with preparations approved for the treatment of hair. Thus, the method of PRP using can be considered as a method of treating AGA, however, it is necessary to continue research for further study and standardization of this technique.

Highlights

  • The actual mechanisms of action on the hair follicle remain controversial: platelet-rich plasma (PRP) activates the proliferation of dermal papilla cells and prevents apoptosis, which provokes an increase in Akt and Bcl-2 expression levels in vitro

  • PRP is involved in the formation of the hair epithelium and the differentiation of stem cells into cells of the hair follicle

  • The authors of this study demonstrated that the treatment of follicular units using PRP before transplantation contributed to an increase in hair growth and density

Read more

Summary

ЧОЛОВІКІВ ТА ЖІНОК

Дана стаття являє собою аналіз наукових публікацій, що відображають досвід застосування аутологічної збагаченої тромбоцитами плазми у пацієнтів з андрогенною алопецією (АГА) – мультифакторіальним захворюванням с генетичною схильністю, зумовлене впливом екзогенних або ендогенних тригерів, відповідальних за клінічні прояви патології. Увага до цієї теми зумовлена значною поширеністю АГА, а також незадовільними результатами у досягненні позитивного терапевтичного ефекту. КЛЮЧОВІ СЛОВА: андрогенна алопеція, аутологічна збагачена тромбоцитами плазма, трихологія, імунологія. АУТОЛОГИЧНАЯ ОБОГАЩЕННАЯ ТРОМБОЦИТАМИ ПЛАЗМА: ОБЗОР НАУЧНЫХ СТАТЕЙ ОБ ИЗУЧЕНИИ ЭФФЕКТИВНОСТИ В ЛЕЧЕНИИ АНДРОГЕНЕТИЧЕСКОЙ

АЛОПЕЦИИ У МУЖЧИН И ЖЕНЩИН
INTRODUCTION
EFFECTS OF GROWTH FACTORS ON THE HAIR FOLLICLE
CONCLUSIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call